Medilink North of England News 2019 Medilink NOE News 2019 | Page 12

MANTRA MEDICAL Medilink North of England is proud to welcome infection control specialists, Mantra Medical as new members. The Doncaster based company develop innovative infection control devices to prevent the spread of everyday, potentially dangerous infections in hospitals. Mantra Medical specifically home in on designing infection control that operates within existing staff workflow patterns, without the need for any extra work. In a hospital environment, every patient interaction carries a risk of spreading infection – particularly with an ageing population and multi-resistant organisms. Despite existing infection control measures, Healthcare Associated Infections (HCAIs) persist – Pulse Oximeters exemplify the problem of infection control in the current healthcare environment. They contact nearly all hospital patients, are a proven vector of infection spread – yet are almost never cleaned according to evidence. Existing cleaning procedures for Pulse Oximeters are too slow, cumbersome and labour-intensive to be performed between each and every patient – giving infection the opportunity to spread. The MantraONE device enables consistent bedside cleaning of Pulse Oximeters between every patient – eliminating the risk of infection while not burdening current staff with extra work. Mantra Medical developed this chemical and mechanical cleaning solution, which is delivered from a replaceable cartridge inside the MantraONE, to replicate effective manual cleaning in five seconds. To learn more visit www.mantramedical.co.uk MEDILINK LAUNCHES STRATEGIC PARTNERSHIP WITH CHINESE LIFE SCIENCE TECHNOLOGY TRANSFER COMPANY Medilink is delighted to announce that it has entered into a strategic partnership with iBridge in China, to achieve the mutual goal of fast tracking the commercialisation of new technology products in the Life Science sector, with iBridge seeking to introduce western health technology companies to Chinese partners and investors.  iBridge TT International Limited, has outstanding connectivity within the Life Science sector across China, which includes medical technology and biotechnology companies, local and national governments, research academy’s, regulatory agencies, financial institutions and high net worth individuals.  Speaking on the new partnership, Kevin Kiely said “Trust is an important element of any partnership and I have known Tiger Tang, the CEO of iBridge, for over ten years when he was the former President of the extremely successful Guangzhou International Biotech Island. I have subsequently got to know Wah-Hui Chu, the Founder and Chairman of iBridge, who has held numerous Executive posts around the world, including the position of President of PepsiCo Beverages in China. I am confident that iBridge has the expertise and connectivity to open up lucrative commercial opportunities for our members”. If you are interested in knowing more about the Medilink / iBridge partnership and what you need to do to take advantage of this opportunity, please contact Medilink at [email protected] TOOKIE ANNOUNCED AS TITCH INDUSTRY AMBASSADOR TITCH, (The Technology Innovation Transforming Child Health) Network, a national healthcare technology network and a long-term Tookie collaborator, has proudly announced Tookie as an Industry Ambassador. This initiative has been created to showcase partnership collaboration as best practice for both SME’s and the NHS within innovation and the Medical Technology development landscape, for the NIHR and NHS. As a ‘Healthcare Innovation Business’, Tookie aims to improve the lives of 12 (CVC) and central lines, while addressing unmet clinical and patient needs. The company has designed, alongside patients, a range of wearable products in order to address these needs and create #AlifeMoreNormal for patients, which is central to the Tookie brand. Stephen Tooke, Commercial Director of Tookie, said: “Our brand is security, safety and patient reassurance. Starting in oncology and dialysis, we’re now venturing into PICC lines, respiratory and nutrition, because there is an unmet need, which we aim to find solutions for in order to help patients.” Titch will further support Tookie in the development of new products and in its NHS adoption journey. Joint case studies, including Tookie’s own NHS adoption journey, will act as a resource to SME’s in helping them understand what steps need to be taken to successfully release a medical device or product into the NHS. TITCH and Tookie believe that this shared initiative will help support new and innovative devices, which is in line with Tookie’s goal of creating #AlifeMoreNormal for patients, when starting on the challenging journey from idea to NHS Adoption. For more information, please visit www.cypmedtech.nihr.ac.uk/titch/ www.tookie.co #ALifeMoreNormal 12